Literature DB >> 10960185

Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT(4) receptor ligands.

O Diouf1, P Depreux, P Chavatte, J H Poupaert.   

Abstract

The indole derivative GR 113808 is currently used as the reference ligand for labelling the 5-HT(4) serotoninergic receptors. Previous works in our laboratories established the bioisosteric equivalency of the indole heterocycle and naphthalene in a series of melatonin receptor ligands. Based on this knowledge we designed new analogues of GR 113808 by introducing two bioisosteric modifications: firstly, the indole ring was replaced by a naphthalene one and secondly, the ester linkage was replaced by an amide group. Compound 8 emerged within this novel series as it displayed high and selective affinity at 5-HT(4) receptors (Ki 5-HT(4) = 6 nM, Ki 5-HT(3) = 100 nM, Ki values at other 5-HT receptors were higher than 1000 nM). Compound 8 is currently undergoing further pharmacological evaluation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960185     DOI: 10.1016/s0223-5234(00)00163-x

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

Review 1.  Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain.

Authors:  Samuel D Banister; Kaavya Krishna Kumar; Vineet Kumar; Brian K Kobilka; Sanjay V Malhotra
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597

2.  Structure-activity relationship exploration of Kv1.3 blockers based on diphenoxylate.

Authors:  William Nguyen; Brittany L Howard; David P Jenkins; Heike Wulff; Philip E Thompson; David T Manallack
Journal:  Bioorg Med Chem Lett       Date:  2012-09-29       Impact factor: 2.823

3.  Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A2A Receptor Inverse Agonists.

Authors:  Flavia Varano; Daniela Catarzi; Erica Vigiani; Fabrizio Vincenzi; Silvia Pasquini; Katia Varani; Vittoria Colotta
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.